Device therapy in the management of congestive heart failure

Asian T. Turer, Sunil V. Rao

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Despite significant advancements in the treatment of heart failure over the past 2 decades, this patient population is still subject to considerably high morbidity and mortality rates. In recent years, the field of device therapy as adjunctive treatment to the medical management of congestive heart failure has grown in the wake of the large number of randomized trials that have demonstrated the safety and efficacy of these devices. The implantable defibrillator currently represents the standard of care in certain segments of the heart failure population, even in those without a prior arrhythmic event. Biventricular pacing systems appear to have a role in heart failure patients with prolongation of their QRS duration in improving ventricular performance and symptoms, if not mortality. Last, the shortage of organs available for orthotopic transplant has heightened interest in using ventricular-assist devices as destination therapy, and although there is evidence for the feasibility for this approach at the current time, there is a next generation of devices that appear even more promising.

Original languageEnglish (US)
Pages (from-to)130-138
Number of pages9
JournalCardiology in Review
Volume13
Issue number3
DOIs
StatePublished - May 2005

Fingerprint

Heart Failure
Equipment and Supplies
Protective Devices
Cardiac Resynchronization Therapy
Heart-Assist Devices
Mortality
Implantable Defibrillators
Therapeutics
Standard of Care
Treatment Failure
Population
Morbidity
Transplants

Keywords

  • Cardiac resynchronization therapy
  • Congestive heart failure
  • Implantable cardioverter-defibrillator
  • Left ventricular assist device

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Device therapy in the management of congestive heart failure. / Turer, Asian T.; Rao, Sunil V.

In: Cardiology in Review, Vol. 13, No. 3, 05.2005, p. 130-138.

Research output: Contribution to journalArticle

@article{f8e116bc2e7841df82457027a8d7f58a,
title = "Device therapy in the management of congestive heart failure",
abstract = "Despite significant advancements in the treatment of heart failure over the past 2 decades, this patient population is still subject to considerably high morbidity and mortality rates. In recent years, the field of device therapy as adjunctive treatment to the medical management of congestive heart failure has grown in the wake of the large number of randomized trials that have demonstrated the safety and efficacy of these devices. The implantable defibrillator currently represents the standard of care in certain segments of the heart failure population, even in those without a prior arrhythmic event. Biventricular pacing systems appear to have a role in heart failure patients with prolongation of their QRS duration in improving ventricular performance and symptoms, if not mortality. Last, the shortage of organs available for orthotopic transplant has heightened interest in using ventricular-assist devices as destination therapy, and although there is evidence for the feasibility for this approach at the current time, there is a next generation of devices that appear even more promising.",
keywords = "Cardiac resynchronization therapy, Congestive heart failure, Implantable cardioverter-defibrillator, Left ventricular assist device",
author = "Turer, {Asian T.} and Rao, {Sunil V.}",
year = "2005",
month = "5",
doi = "10.1097/01.crd.0000151498.75329.71",
language = "English (US)",
volume = "13",
pages = "130--138",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Device therapy in the management of congestive heart failure

AU - Turer, Asian T.

AU - Rao, Sunil V.

PY - 2005/5

Y1 - 2005/5

N2 - Despite significant advancements in the treatment of heart failure over the past 2 decades, this patient population is still subject to considerably high morbidity and mortality rates. In recent years, the field of device therapy as adjunctive treatment to the medical management of congestive heart failure has grown in the wake of the large number of randomized trials that have demonstrated the safety and efficacy of these devices. The implantable defibrillator currently represents the standard of care in certain segments of the heart failure population, even in those without a prior arrhythmic event. Biventricular pacing systems appear to have a role in heart failure patients with prolongation of their QRS duration in improving ventricular performance and symptoms, if not mortality. Last, the shortage of organs available for orthotopic transplant has heightened interest in using ventricular-assist devices as destination therapy, and although there is evidence for the feasibility for this approach at the current time, there is a next generation of devices that appear even more promising.

AB - Despite significant advancements in the treatment of heart failure over the past 2 decades, this patient population is still subject to considerably high morbidity and mortality rates. In recent years, the field of device therapy as adjunctive treatment to the medical management of congestive heart failure has grown in the wake of the large number of randomized trials that have demonstrated the safety and efficacy of these devices. The implantable defibrillator currently represents the standard of care in certain segments of the heart failure population, even in those without a prior arrhythmic event. Biventricular pacing systems appear to have a role in heart failure patients with prolongation of their QRS duration in improving ventricular performance and symptoms, if not mortality. Last, the shortage of organs available for orthotopic transplant has heightened interest in using ventricular-assist devices as destination therapy, and although there is evidence for the feasibility for this approach at the current time, there is a next generation of devices that appear even more promising.

KW - Cardiac resynchronization therapy

KW - Congestive heart failure

KW - Implantable cardioverter-defibrillator

KW - Left ventricular assist device

UR - http://www.scopus.com/inward/record.url?scp=17844381842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844381842&partnerID=8YFLogxK

U2 - 10.1097/01.crd.0000151498.75329.71

DO - 10.1097/01.crd.0000151498.75329.71

M3 - Article

VL - 13

SP - 130

EP - 138

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 3

ER -